Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Abridged summary of the Cochrane Review.

Schmidt S, Kunath F, Coles B, Draeger DL, Krabbe LM, Dersch R, Kilian S, Jensen K, Dahm P, Meerpohl JJ

Open source

DOI
10.4111/icu.2020.61.4.349
Published
2020 Jul
Container
Investigative and clinical urology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4111/icu.2020.61.4.349,
  title = {Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Abridged summary of the Cochrane Review.},
  author = {Schmidt S and Kunath F and Coles B and Draeger DL and Krabbe LM and Dersch R and Kilian S and Jensen K and Dahm P and Meerpohl JJ},
  year = {2020},
  journal = {Investigative and clinical urology},
  doi = {10.4111/icu.2020.61.4.349},
  url = {https://doi.org/10.4111/icu.2020.61.4.349}
}

RIS

TY  - JOUR
TI  - Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Abridged summary of the Cochrane Review.
AU  - Schmidt S
AU  - Kunath F
AU  - Coles B
AU  - Draeger DL
AU  - Krabbe LM
AU  - Dersch R
AU  - Kilian S
AU  - Jensen K
AU  - Dahm P
AU  - Meerpohl JJ
PY  - 2020
JO  - Investigative and clinical urology
DO  - 10.4111/icu.2020.61.4.349
UR  - https://doi.org/10.4111/icu.2020.61.4.349
ER  - 

APA

S, S., F, K., B, C., DL, D., LM, K., R, D., S, K., K, J., P, D., & JJ, M. (2020). Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer: Abridged summary of the Cochrane Review.. Investigative and clinical urology. https://doi.org/10.4111/icu.2020.61.4.349

Source records